Statins: potential new indications in inflammatory conditions.
about
A Dormant Microbial Component in the Development of PreeclampsiaIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesRheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review.Clinical significance of the humoral immune response to modified LDL.Curing the Toxicity of Multi-Walled Carbon Nanotubes through Native Small-molecule Drugs.Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigationExposure to statins and risk of common cancers: a series of nested case-control studies.Statins are associated with reduced risk of gastric cancer: a meta-analysis.Statins: a perspective for left ventricular hypertrophy treatment.Anti-inflammatory effect of simvastatin in hemodialysis patients.Do statins improve outcomes in patients with asthma on inhaled corticosteroid therapy? A retrospective cohort analysisThe connection between C-reactive protein and atherosclerosisUse of statins and blood pressure.Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammationSimvastatin suppresses LPS-induced MMP-1 expression in U937 mononuclear cells by inhibiting protein isoprenylation-mediated ERK activation.Advances in hemorrhagic stroke therapy: conventional and novel approaches.Atherogenesis and the humoral immune response to modified lipoproteinsStatin treatment, carotid atherosclerotic plaque macrophage infiltration and circulating inflammatory markersAntioxidant therapy in multiple sclerosis.Prostaglandins in pathogenesis and treatment of multiple sclerosis.The association between psoriasis and dyslipidaemia: a systematic review.The Effect of Locally Delivered Statins on Treating Periodontal Intrabony Defects: A Systematic Review and Meta-Analysis.Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers.Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo.Endothelial progenitor cells: Exploring the pleiotropic effects of statinsHMG-CoA reductase inhibitor lovastatin causes reversible cytoskeleton perturbation by RhoA signalling suppression in peritoneal cell line Met5A.Analysis of drug-endogenous human metabolite similarities in terms of their maximum common substructures.Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome.Protective effect of simvastatin in the cyclophosphamide-induced hemorrhagic cystitis in rats.Tooth loss, periodontitis, and statins in a population-based follow-up study.Common cancer risk and statins: a population-based case-control study in a Chinese population.Effect of statins on soluble CD40 ligand in hypercholesterolemic Type 2 diabetic patients.Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration.Simvastatin Attenuates Neuropathic Pain by Inhibiting the RhoA/LIMK/Cofilin Pathway.
P2860
Q28069689-B62DDE9C-59A2-444D-9D5C-A23FA827CD75Q28388335-F5750C1A-9976-451D-BD45-65C73923AFBFQ33307666-980DB85F-F175-43B9-BE68-F4958A5BFB91Q33598770-10760CE0-E7E5-445C-B498-684EE7BA9CC4Q33767566-072A1576-6C1E-43B9-9149-1B032EBEBF4EQ33890221-B86E34F3-2E53-4230-9F87-0AB9D8D7ADB1Q34028899-19CF4233-37F7-4555-A504-1E9438E48DEDQ34349560-F4FD0548-014C-44A0-8B46-26D47C91A624Q34662787-D6F5B896-8476-48AC-9705-37AFE1073842Q35279257-825B3FC1-FF37-4875-8757-17C00AA1A1D1Q35999292-9CF75F2C-E419-4DBF-91D8-A36A1DB0F79DQ35999439-DEE742DB-6D4B-4696-9DB6-2CF4272CD070Q36092447-2BD2B942-FE01-4401-813A-EA2B7B310BD0Q36665257-0256974D-9EDA-431B-BCBF-142120CF426BQ36882289-4B5BA023-4257-4327-98F9-429C27DBA0C3Q36944012-011B9977-6E6D-4E9C-9E51-82645A94C3BFQ37021490-7DDE7714-4E84-4B3E-85ED-94106E3C6909Q37063945-1853A463-77BA-4742-B459-04B6185F87B3Q37258404-932C0B0C-B919-438F-B774-A100AF5DC7E0Q37710103-EB95634E-3DEE-43A3-835A-7C919416F049Q38056160-C7044888-39E6-45D4-B4BD-F751931B5226Q38987341-5EA49F69-1D52-4711-8C17-21D32D8449FEQ39012650-42197EB5-E1DA-4D65-ADEB-B4494B77FB54Q39107997-EF883F4F-EE81-4DF2-B1C7-06D36874E64EQ39121106-4FAF92B9-1682-4DF9-A1D7-BC8E1F31A0D7Q39705806-2B48904F-2222-4FD7-AAA7-877236939A7FQ41959283-6EDA9A50-50BF-44FA-9CC4-1DF069E917F8Q42133595-672305DD-A872-4BF0-9028-75F0FA5B4638Q43176594-CA574912-03EF-4358-8C7A-AB425B5A6AB4Q44012981-BADE57F1-3EC1-4B55-B280-E8A122DB4443Q44270613-FBE030F2-5BCB-4120-8792-A24E7F1C1994Q46372426-FA3A35C3-F126-4564-9597-1C2460690BCAQ48198673-C8D55FF7-6A0B-4774-9CEE-C0C26116CCF1Q53095867-43642508-384C-49D8-AAA8-76CB583A9908
P2860
Statins: potential new indications in inflammatory conditions.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Statins: potential new indications in inflammatory conditions.
@ast
Statins: potential new indications in inflammatory conditions.
@en
type
label
Statins: potential new indications in inflammatory conditions.
@ast
Statins: potential new indications in inflammatory conditions.
@en
prefLabel
Statins: potential new indications in inflammatory conditions.
@ast
Statins: potential new indications in inflammatory conditions.
@en
P1476
Statins: potential new indications in inflammatory conditions.
@en
P2093
Matthias Endres
P356
10.1016/J.ATHEROSCLEROSISSUP.2006.01.005
P577
2006-02-28T00:00:00Z